Speak directly to the analyst to clarify any post sales queries you may have.
Capillary columns are at the forefront of biopharmaceutical analytical processes, offering unmatched resolution and reliability essential for next-generation drug development. As the biopharma industry prioritizes precision, these columns deliver the performance edge required by leaders navigating rapidly evolving global markets.
Market Snapshot: Biopharmaceutical Capillary Column Market
The biopharmaceutical capillary column market is characterized by robust expansion, fueled by technology innovation and heightened complexity in analytical requirements. Evolving regulatory standards and a dynamic supply chain environment continue to influence technology adoption, supply strategies, and collaborative development among manufacturers. The increased focus on reproducibility, automation, and sustainability is reshaping global demand, while localized production and diversified procurement drive supply resilience.
Scope & Segmentation of the Market
This report provides comprehensive segmentation, highlighting the breadth of capillary column applications and end users within biopharma:
- Applications: Bioanalysis, Metabolite Profiling, Purity Analysis, Quality Control (Assay Validation, Stability Testing), Research and Development (Method Development, Method Optimization)
- End Users: Academic and Research Institutions, Biotech Companies, Contract Research Organizations, Pharmaceutical Companies
- Column Types: Fused Silica, Metal, Polymer
- Particle Sizes: 1.7 µm, 3 µm, 5 µm
- Column Lengths: 10 m, 15 m, 30 m
- Stationary Phases: Ionic Liquid, Metal Oxide, Polymer-Based, Silica-Based
- Geographies: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
- Companies Covered: Agilent Technologies, Inc.; Thermo Fisher Scientific Inc.; Waters Corporation; Shimadzu Corporation; Restek Corporation; Merck KGaA; PerkinElmer, Inc.; GL Sciences Inc.; Trajan Scientific and Medical Pty Ltd; SGE Analytical Science Pty Ltd
Key Takeaways for Senior Decision-Makers
- Technological advances—such as novel stationary phases and high-pressure instrument compatibility—are propelling separation science innovation and analytics efficiency.
- Automation and digital analytics platforms support workflow optimization, reducing manual intervention in both R&D and quality control environments.
- Sustainability initiatives are shaping procurement priorities, driving interest in reusable column formats and solvent-reduction practices across the supply chain.
- Regional differences, particularly in Asia-Pacific and EMEA, impact technology adoption and partnership models, reflecting distinctive regulatory, cost, and manufacturing preferences.
- Collaborative alliances between manufacturers, research institutions, and end users are vital for accelerating development and commercial deployment of next-generation capillary columns.
Tariff Impact: 2025 US Adjustments
Anticipated tariff adjustments in 2025 are set to introduce new cost pressures for capillary column raw materials, impacting global sourcing strategies. Industry leaders are building production agility and reconfiguring supply chains, including partnerships and inventory management, to ensure uninterrupted operations and maintain resilience against trade-related disruptions.
Research Methodology & Data Sources
Our market intelligence leverages a hybrid research methodology, incorporating direct interviews with experts and secondary analysis from peer-reviewed publications, industry white papers, and conference proceedings. Findings are validated through rigorous triangulation with input from vendors, researchers, and end users, ensuring data integrity and actionable insights.
Why This Report Matters
- Senior decision-makers gain a holistic view of critical market drivers—technology, regulation, and supply dynamics—enabling informed strategic choices.
- The report enables benchmarking against leading players and best practices, facilitating competitive positioning and innovation planning.
Conclusion
Comprehensive market insights presented in this report inform strategic investment and operational decisions. Capillary column advancements will continue to enable analytical rigor and supply chain agility in biopharmaceutical development.
This product will be delivered within 1-3 business days.
Table of Contents
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4.2. Market Sizing & Forecasting
5.2. Emergence of silicon-based microstructured capillary columns for enhanced biomolecule resolution
5.3. Adoption of column surface chemistries tailored for glycoprotein and peptide variant profiling
5.4. Integration of capillary columns with mass spectrometry workflows for biopharmaceutical impurity analysis
5.5. Utilization of 3D-printed capillary column housings to reduce manufacturing costs and customization
5.6. Advancements in temperature-programmed capillary column technology for improved protein stability assays
5.7. Growth of regulatory guidance driving standardized validation protocols for biopharma capillary columns
5.8. Rise of polymer-based stationary phases in capillary columns to improve biomolecular separation performance
6.2. PESTLE Analysis
8.2. Bioanalysis
8.3. Metabolite Profiling
8.4. Purity Analysis
8.5. Quality Control
8.5.1. Assay Validation
8.5.2. Stability Testing
8.6. Research And Development
8.6.1. Method Development
8.6.2. Method Optimization
9.2. Academic And Research Institutions
9.3. Biotech Companies
9.4. Contract Research Organizations
9.5. Pharmaceutical Companies
10.2. Fused Silica
10.3. Metal
10.4. Polymer
11.2. 1.7 µm
11.3. 3 µm
11.4. 5 µm
12.2. 10 m
12.3. 15 m
12.4. 30 m
13.2. Ionic Liquid
13.3. Metal Oxide
13.4. Polymer-Based
13.5. Silica-Based
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Agilent Technologies, Inc.
17.3.2. Thermo Fisher Scientific Inc.
17.3.3. Waters Corporation
17.3.4. Shimadzu Corporation
17.3.5. Restek Corporation
17.3.6. Merck KGaA
17.3.7. PerkinElmer, Inc.
17.3.8. GL Sciences Inc.
17.3.9. Trajan Scientific and Medical Pty Ltd
17.3.10. SGE Analytical Science Pty Ltd
FIGURE 2. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET: RESEARCHAI
FIGURE 28. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET: RESEARCHSTATISTICS
FIGURE 29. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET: RESEARCHCONTACTS
FIGURE 30. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET: RESEARCHARTICLES
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY BIOANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY BIOANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METABOLITE PROFILING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METABOLITE PROFILING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PURITY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PURITY ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY ASSAY VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY ASSAY VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STABILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METHOD DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METHOD DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METHOD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METHOD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY FUSED SILICA, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY FUSED SILICA, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 1.7 ?M, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 1.7 ?M, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 3 ?M, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 3 ?M, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 5 ?M, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 5 ?M, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 10 M, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 10 M, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 15 M, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 15 M, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 30 M, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 30 M, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY IONIC LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY IONIC LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METAL OXIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METAL OXIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY SILICA-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY SILICA-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 116. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 117. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 118. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 119. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 124. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 125. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 126. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 127. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 128. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 133. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 134. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 135. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 138. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 139. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 142. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 143. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 214. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 215. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 216. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 217. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 220. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 223. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 224. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 225. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 226. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 230. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 231. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 232. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 233. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 236. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 237. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 239. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 240. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 241. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 242. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 259. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 262. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 263. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 264. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 265. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 268. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 269. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 270. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 271. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 272. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 273. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 274. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. SPAIN CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. SPAIN CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY Q
Samples
LOADING...
Companies Mentioned
The companies profiled in this Capillary Columns for Biopharmaceuticals Market report include:- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Waters Corporation
- Shimadzu Corporation
- Restek Corporation
- Merck KGaA
- PerkinElmer, Inc.
- GL Sciences Inc.
- Trajan Scientific and Medical Pty Ltd
- SGE Analytical Science Pty Ltd